Literature DB >> 17823265

Hypoglycemia with enhanced hepatic glycogen synthesis in recombinant mice lacking hexose-6-phosphate dehydrogenase.

Gareth G Lavery1, David Hauton, Kylie N Hewitt, Sophie M Brice, Mark Sherlock, Elizabeth A Walker, Paul M Stewart.   

Abstract

Hexose-6-phosphate dehydrogenase (H6PDH) knockout (KO) mice have reduced generation of nicotinamide adenine dinucleotide phosphate (reduced) within the endoplasmic reticulum. As a consequence, 11beta-hydroxysteroid dehydrogenase type 1 enzyme activity switches from a reductase to a dehydrogenase leading to glucocorticoid inactivation. 11beta-Hydroxysteroid dehydrogenase type 1 has emerged as an important factor in regulating hepatic glucose output; therefore, we examined aspects of glucose homeostasis in KO mice. Compared with wild-type mice, KO mice reduced weight gain, displayed peripheral fasting hypoglycemia, improved glucose tolerance, and elevated plasma corticosterone concentrations. Plasma insulin levels in fed and fasted KO mice are normal; however, insulin and plasma glucose levels are reduced 4 h after fasted animals are refed, indicating improved insulin sensitivity. There is preserved induction and activity of the glucocorticoid-responsive gluconeogenic enzymes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in fasted KO mice. Glycogen storage is elevated in fed KO liver, with fed glycogenesis rates increased in KO mice. There is normal flux of lactate through gluconeogenesis recovered as plasma glucose, coupled with increased glycogen derived from lactate. These data suggest partial retention of glucocorticoid sensitivity at the level of the liver. We therefore postulate that increased glycogen synthesis may reflect increased flux of glucose-6-phosphate (H6PDH substrate) through to glycogen in the absence of H6PDH mediated metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823265     DOI: 10.1210/en.2007-0963

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

2.  Involvement of GR and p300 in the induction of H6PD by cortisol in human amnion fibroblasts.

Authors:  Weihua Wang; Chunming Guo; Wenjiao Li; Jianneng Li; Wangsheng Wang; Leslie Myatt; Kang Sun
Journal:  Endocrinology       Date:  2012-11-02       Impact factor: 4.736

3.  Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy.

Authors:  Gareth G Lavery; Elizabeth A Walker; Nil Turan; Daniela Rogoff; Jeffery W Ryder; John M Shelton; James A Richardson; Francesco Falciani; Perrin C White; Paul M Stewart; Keith L Parker; Daniel R McMillan
Journal:  J Biol Chem       Date:  2008-01-25       Impact factor: 5.157

4.  Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Nina M Semjonous; Mark Sherlock; Pancharatnam Jeyasuria; Keith L Parker; Elizabeth A Walker; Paul M Stewart; Gareth G Lavery
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

5.  Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11β-HSD1-mediated glucocorticoid activation in hepatic cells.

Authors:  Denise V Kratschmar; Diego Calabrese; Jo Walsh; Adam Lister; Julia Birk; Christian Appenzeller-Herzog; Pierre Moulin; Chris E Goldring; Alex Odermatt
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

6.  Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Gareth G Lavery; Agnieszka E Zielinska; Laura L Gathercole; Beverly Hughes; Nina Semjonous; Phillip Guest; Khalid Saqib; Mark Sherlock; Gary Reynolds; Stuart A Morgan; Jeremy W Tomlinson; Elizabeth A Walker; Elizabeth H Rabbitt; Paul M Stewart
Journal:  Endocrinology       Date:  2012-05-03       Impact factor: 4.736

7.  Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH.

Authors:  Lianne Abrahams; Nina M Semjonous; Phil Guest; Agnieszka Zielinska; Beverly Hughes; Gareth G Lavery; Paul M Stewart
Journal:  J Endocrinol       Date:  2012-06-20       Impact factor: 4.286

8.  Does long-term metformin treatment increase cardiac lipoprotein lipase?

Authors:  David Hauton
Journal:  Metabolism       Date:  2010-02-12       Impact factor: 8.694

9.  Maternal hypoxia decreases capillary supply and increases metabolic inefficiency leading to divergence in myocardial oxygen supply and demand.

Authors:  David Hauton; Abdullah Al-Shammari; Eamonn A Gaffney; Stuart Egginton
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

10.  Thymic function is maintained during Salmonella-induced atrophy and recovery.

Authors:  Ewan A Ross; Ruth E Coughlan; Adriana Flores-Langarica; Sian Lax; Julia Nicholson; Guillaume E Desanti; Jennifer L Marshall; Saeeda Bobat; Jessica Hitchcock; Andrea White; William E Jenkinson; Mahmood Khan; Ian R Henderson; Gareth G Lavery; Christopher D Buckley; Graham Anderson; Adam F Cunningham
Journal:  J Immunol       Date:  2012-09-19       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.